Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Revenue 2016–2025
Oramed Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Oramed Pharmaceuticals Inc. revenue for the quarter ending March 31, 2025 was 2.0 M, a 200.30% increase year-over-year.
- Oramed Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2025 was 4.0 M, a 37.83% increase year-over-year.
- Oramed Pharmaceuticals Inc. annual revenue for 2025 was 2.0 M, a 49.25% increase from 2023.
- Oramed Pharmaceuticals Inc. annual revenue for 2023 was 1.3 M, a 50.43% decrease from 2022.
- Oramed Pharmaceuticals Inc. annual revenue for 2022 was 2.7 M, a 0.00% increase from 2021.
- Oramed Pharmaceuticals Inc. annual revenue for 2021 was 2.7 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Oramed Pharmaceuticals Inc. Market Cap — FAQ
Oramed Pharmaceuticals Inc. (ORMP) market cap over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ORMP's market cap history?
The chart and table above show Oramed Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.